Norgestimate OCP’s have the following advantage except:
**Core Concept**
Norgestimate is a progestin used in oral contraceptive pills (OCPs) that exhibit a unique pharmacological profile. The pharmacokinetics of norgestimate OCPs allow for a lower dose of ethinyl estradiol (EE) while maintaining effective contraception.
**Why the Correct Answer is Right**
Norgestimate OCPs have a higher ratio of progestin to estrogen, which enables the use of lower doses of ethinyl estradiol. This is particularly beneficial as it reduces the risk of estrogen-related side effects and thromboembolic events. Additionally, norgestimate's active metabolite, 17-deacetyl norgestimate, has a longer half-life, allowing for once-daily dosing.
**Why Each Wrong Option is Incorrect**
**Option A:** This choice is incorrect as norgestimate OCPs do not have a higher risk of weight gain, but rather a favorable lipid profile.
**Option B:** This option is incorrect as norgestimate OCPs actually have a lower risk of breakthrough bleeding, making them a suitable choice for women with irregular cycles.
**Option C:** This option is incorrect as norgestimate OCPs are not associated with an increased risk of hypertension, but rather a neutral effect on blood pressure.
**Clinical Pearl / High-Yield Fact**
Norgestimate OCPs are a good choice for women with a history of hypertension or those at risk for thromboembolic events due to their favorable lipid profile and lower risk of estrogen-related side effects.
**Correct Answer: D.**